Fig. 3From: Surface modification of cobalt oxide nanoparticles using phosphonomethyl iminodiacetic acid followed by folic acid: a biocompatible vehicle for targeted anticancer drug deliveryPercentage of folic acid binding (a), percentage of protein binding with FA-PMIDA-CoO nanoparticles (b), and percentage of protein release in sup (c)Back to article page